NCT04573387

Brief Summary

A prospective, multicenter, randomized controlled trial is designed to compare the recurrence rates and clinical outcomes in patients with chronic subdural hematoma using exhaustive drainage or fixed-time drainage after one-burr hole craniostomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
309

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

17 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 5, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

December 29, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

December 30, 2024

Status Verified

December 1, 2024

Enrollment Period

3.5 years

First QC Date

September 26, 2020

Last Update Submit

December 26, 2024

Conditions

Keywords

chronic subdural hematomafixed-time drainageexhaustive drainagedrainagecraniostomyurokinase

Outcome Measures

Primary Outcomes (1)

  • Rate of re-operations of chronic subdural hematoma

    Rate of re-operations between fixed-time drainage group and exhaustive drainage group

    From operation up to 6 months postoperatively

Secondary Outcomes (5)

  • Change of Modified Rankin Scale (MRS) between groups from baseline to 6 months after operation

    At baseline, and at 1, 3, and 6 months after operation

  • Change of Markwalder Grading Scale (MGS) between groups from baseline to 6 months after operation

    At baseline, and at 1, 3, and 6 months after operation

  • Change of health related quality of life between groups from baseline to 6 months after operation

    At baseline, and at 1, 3, and 6 months after operation

  • Rate of mortality between groups within 6 months

    From operation up to 6 months postoperatively

  • Rate of complications and adverse events between groups within 6 months

    From operation up to 6 months postoperatively

Study Arms (2)

Fixed-time drainage

ACTIVE COMPARATOR

Drainage will be removed after 48 hours.

Procedure: OperationProcedure: Fixed-time drainageProcedure: Postoperative computed tomography

Exhaustive drainage

EXPERIMENTAL

Drainage will be removed when postoperative hematoma volume is minimized with repeated urokinase injection into hematoma cavity through catheter.

Procedure: OperationProcedure: Exhaustive drainageProcedure: Postoperative computed tomography

Interventions

OperationPROCEDURE

All participants are treated with burr-hole craniotomy and a drainage system as follows. Participants undergo surgical procedure under local anesthesia in the hemisphere with a lateral position, but general anesthesia is performed when participant cannot tolerate the operation. A single 1.5 cm burr hole is drilled over the maximum width of the hematoma cavity. After coagulating with bipolar diathermy, dura mater is opened with a cruciate incision. A soft catheter is placed carefully in all directions of the hematoma cavity for irrigating subdural collections with 1,000 mL warm Ringer's lactate saline until clarification. The drainage catheter is inserted ½ length of the maximum diameter of the hematoma cavity toward the frontal region. After the skin is closed, the catheter was connected to a soft collection bag that is placed under the head for passive drainage. During the drainage period, participants stay in bed until the drain is removed.

Exhaustive drainageFixed-time drainage

All participants will be treated with a one-burr-hole craniotomy with irrigation and a closed drainage system. The drainage will be removed after 48 hours.

Fixed-time drainage

All participants will be treated with a one-burr-hole craniotomy with irrigation and a closed drainage system. If the computed tomography (CT) scan on the first day after surgery indicates that the affected brain region shows sufficient re-expansion, the drainage catheter will be removed when drainage ceases. If subdural collections remain in the hematoma cavity, the participant will be treated with 30,000 U urokinase injection into the hematoma cavity through the catheter. The catheter will be closed and reopened in 1.5-2 hours, and a CT scan will be performed when drainage ceases. If the CT scan shows sufficient re-expansion of the brain, the catheter will be removed. However, if the brain does not show good re-expansion and there is still a residual subdural collection, the above steps will be repeated. If the participant is subjected to urokinase injection for 3 times, the catheter will be removed when drainage ceases.

Exhaustive drainage

All participants undergo a CT scan before the drain is removed, and the last CT scan will be performed before the patient is discharged from the hospital.

Exhaustive drainageFixed-time drainage

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient (18 years to 90 years) presenting with clinical symptoms and neurological deficits of chronic subdural hematoma
  • Chronic subdural hematoma verified on cranial computed tomography or magnetic resonance imaging
  • Written informed consent from patients or their next of kin according to the patient's cognitive status

You may not qualify if:

  • No clinical symptoms correlating with chronic subdural hematoma
  • Lack of mass effect, less than 0.5 cm of midline structure shift, and no need surgery judged clinically by neurosurgeons
  • Previous surgery for chronic subdural hematoma during the past 6 months
  • Previous intracranial surgery for any neurological disorders but chronic subdural hematoma before
  • Existing poor medication condition or severe comorbidity so that surgery cannot be tolerated or follow-up cannot be completed
  • Severe coagulopathy or high risk of life-threatening bleeding
  • Postoperative cooperation is suspected to be insufficient for follow-up for 6 months
  • Reproductive-age women without verified negative pregnancy testing
  • Participating in other research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Beijing Ditan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100015, China

Location

Beijing Chaoyang Hospital, Capital Medical University

Beijing, Beijing Municipality, 100020, China

Location

Beijing Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, 100053, China

Location

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100070, China

Location

Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, 100730, China

Location

Beijing Luhe Hospital, Capital Medical University

Beijing, Beijing Municipality, 101100, China

Location

Wangjing Hospital, China Academy of Chinese Medical Sciences

Beijing, Beijing Municipality, China

Location

Puning People's Hospital

Puning, Guangdong, 515300, China

Location

Wei County Hospital of Traditional Chinese Medicine

Handan, Hebei, 056800, China

Location

Hengshui People's Hospital

Hengshui, Hebei, 053000, China

Location

First Hospital of Qinhuangdao

Qinhuangdao, Hebei, 066000, China

Location

North China University of Science and Technology Affiliated Hospital

Tangshan, Hebei, 063000, China

Location

Xiahuayuan District Hospital

Zhangjiakou, Hebei, 075000, China

Location

First People's Hospital of Lianyungang

Lianyungang, Jiangsu, 222061, China

Location

Yancheng Third People's Hospital

Yancheng, Jiangsu, 224001, China

Location

People's Hospital of Ningxia Hui Autonomous Region

Yinchuan, Ningxia, 750002, China

Location

Tianjin Huanhu Hospital

Tianjin, Tianjin Municipality, 300350, China

Location

Related Publications (7)

  • Ou Y, Yu X, Liu X, Jing Q, Liu B, Liu W. A Comparative Study of Chronic Subdural Hematoma in Patients With and Without Head Trauma: A Retrospective Cross Sectional Study. Front Neurol. 2020 Nov 27;11:588242. doi: 10.3389/fneur.2020.588242. eCollection 2020.

    PMID: 33329333BACKGROUND
  • Ou Y, Dong J, Wu L, Xu L, Wang L, Liu B, Li J, Liu W. An Exhaustive Drainage Strategy in Burr-hole Craniostomy for Chronic Subdural Hematoma. World Neurosurg. 2019 Jun;126:e1412-e1420. doi: 10.1016/j.wneu.2019.03.111. Epub 2019 Mar 19.

    PMID: 30902781BACKGROUND
  • Ou Y, Dong J, Wu L, Xu L, Wang L, Liu B, Li J, Liu W. The Clinical Characteristics, Treatment, and Outcomes of Chronic Subdural Hematoma in Young Patients. World Neurosurg. 2019 May;125:e1241-e1246. doi: 10.1016/j.wneu.2019.02.017. Epub 2019 Feb 22.

    PMID: 30797913BACKGROUND
  • Ou Y, Dong J, Wu L, Xu L, Wang L, Liu B, Li J, Liu W. A comparative study of chronic subdural hematoma in three age ranges: Below 40 years, 41-79 years, and 80 years and older. Clin Neurol Neurosurg. 2019 Mar;178:63-69. doi: 10.1016/j.clineuro.2019.01.018. Epub 2019 Jan 29.

    PMID: 30716602BACKGROUND
  • Liu W, Bakker NA, Groen RJ. Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg. 2014 Sep;121(3):665-73. doi: 10.3171/2014.5.JNS132715. Epub 2014 Jul 4.

    PMID: 24995782BACKGROUND
  • Wu L, Ou Y, Liu W. Letter to the Editor. Benefit of postoperative computed tomography in chronic subdural hematoma. J Neurosurg. 2019 Sep 13;131(6):1992-1993. doi: 10.3171/2019.5.JNS191212. Print 2019 Dec 1. No abstract available.

    PMID: 31518980BACKGROUND
  • Wu L, Ou Y, Zhu B, Guo X, Yu X, Xu L, Li J, Feng E, Li H, Wang X, Chen H, Sun Z, Liu Z, Yang D, Zhang H, Liu Z, Tang J, Zhao S, Zhang G, Yao J, Ma D, Sun Z, Zhou H, Liu B, Liu W; ECHO Trial Collaborators. Exhaustive drainage versus fixed-time drainage for chronic subdural hematoma after one-burr hole craniostomy (ECHO): study protocol for a multicenter randomized controlled trial. Trials. 2023 Mar 20;24(1):207. doi: 10.1186/s13063-023-07250-y.

MeSH Terms

Conditions

Hematoma, Subdural, Chronic

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Hematoma, SubduralIntracranial Hemorrhage, TraumaticIntracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemVascular DiseasesCardiovascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHematomaHemorrhageWounds and Injuries

Study Officials

  • Weiming Liu, MD

    Beijing Tiantan Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The design is open labeled with only the investigators for postoperative follow-up evaluation, the outcome assessors, and data analysts being blinded in all 19 centers. Before outcome assessment begins at every follow-up evaluation, the patients will be reminded not to reveal any information about their group allocation. If details of group allocation can be detected by the investigator during follow-ups, another blinded researcher will replace to evaluate outcome.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 26, 2020

First Posted

October 5, 2020

Study Start

December 29, 2020

Primary Completion

July 9, 2024

Study Completion

December 15, 2024

Last Updated

December 30, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations